Gene · 719
Papers2,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism. | J Biol Chem | 2024 | 38072064 | PubTator, text mining | PubMed |
| Complement in human disease: approved and up-and-coming therapeutics. | Lancet | 2024 | 37979593 | PubTator, text mining | PubMed |
| Evidence from Machine Learning, Diagnostic Hub Genes in Sepsis and Diagnostic Models based on Xgboost Models, Novel Molecular Models for the Diagnosis of Sepsis. | Curr Med Chem | 2024 | 37921181 | PubTator, text mining | PubMed |
| Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage. | Hypertension | 2024 | 37909169 | PubTator, text mining | PubMed |
| Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy. | J Diabetes Investig | 2024 | 37737517 | PubTator, text mining | PubMed |
| Damage to endothelial barriers and its contribution to long COVID. | Angiogenesis | 2024 | 37103631 | PubTator, text mining | PubMed |
| KLF4 and CD55 expression and function depend on each other. | Front Immunol | 2023 | 38406578 | PubTator, text mining | PubMed |
| Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy. | Front Immunol | 2023 | 38288116 | PubTator, text mining | PubMed |
| Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma. | Front Immunol | 2023 | 38274805 | PubTator, text mining | PubMed |
| The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome. | Biomolecules | 2023 | 38254639 | PubTator, text mining | PubMed |
| Choroidal Mast Cells and Pathophysiology of Age-Related Macular Degeneration. | Cells | 2023 | 38201254 | PubTator, text mining | PubMed |
| Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy. | Front Immunol | 2023 | 38193080 | PubTator, text mining | PubMed |
| Interorgan communication with the liver: novel mechanisms and therapeutic targets. | Front Immunol | 2023 | 38155961 | PubTator, text mining | PubMed |
| Citrullinated and MMP-degraded vimentin is associated with chronic pulmonary diseases and genetic variants in PADI3/PADI4 and CFH in postmenopausal women. | Sci Rep | 2023 | 38155185 | PubTator, text mining | PubMed |
| Analysis of complement system and its related factors in Alzheimer's disease. | BMC Neurol | 2023 | 38114984 | PubTator, text mining | PubMed |
| [Value of the expression levels of complement-3a receptor 1 and neutrophil extracellular traps in predicting sepsis-induced coagulopathy]. | Zhongguo Dang Dai Er Ke Za Zhi | 2023 | 38112144 | PubTator, text mining | PubMed |
| Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC. | Front Oncol | 2023 | 38090482 | PubTator, text mining | PubMed |
| Association of plasma MMP-2 levels and prognosis of patients with intracerebral hemorrhage: a prospective cohort study. | Front Neurol | 2023 | 38090262 | PubTator, text mining | PubMed |
| C3a/C3aR synergies with TGF-β to promote epithelial-mesenchymal transition of renal tubular epithelial cells via the activation of the NLRP3 inflammasome. | J Transl Med | 2023 | 38082306 | PubTator, text mining | PubMed |
| Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages. | Comput Struct Biotechnol J | 2023 | 38074471 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/719/papers?page=10